Concepedia

Dianxiong Zou

DZ

4

Publications

153

Citations

4

H-Index

2019

Active since

Affiliations

Texas A&M University(Current)

Baylor College of Medicine

University of Alabama

Dianxiong Zou is an author at Texas A&M University specializing in medicine, pharmacology, and engineering.

ORCID

Top concepts

Publications per year

2019–2022

4

Publications

4

Oral delivery of nanoparticle urolithin A normalizes cellular stress and improves survival in mouse model of cisplatin-induced AKI

Dianxiong Zou, Raghu Ganugula, Meenakshi Arora et al. · American Journal of Physiology-Renal Physiology · 2019 · 57 citations · Full text

A highly potent lymphatic system–targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus

Raghu Ganugula, Meenakshi Arora, Dianxiong Zou et al. · Science Advances · 2020 · 53 citations · Full text

Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis

Raghu Ganugula, Nikhil K. Nuthalapati, Subhash Dwivedi et al. · Journal of Controlled Release · 2022 · 28 citations · Full text

, , +8

Nanoparticles that do not compete with endogenous ligands – Molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans

Dianxiong Zou, Meenakshi Arora, Raghu Ganugula et al. · Journal of Controlled Release · 2021 · 15 citations · Full text

, , +11

Rows per page

1–4 of 4